NewsEvents

Your Yourlocation: Home > Treatment of chronic obstructive pulmonary disease with tiotropium bromide(136310-93-5) powder inhalation

Guangzhou Panyu District Central Hospital, Department of Respiratory Medicine researchers published papers to explore the tiotropium bromide(136310-93-5) inhalation in the treatment of chronic obstructive pulmonary disease clinical effect, for COPD patients with clinical use of reference. Studies have shown that the use of tiotropium bromide(136310-93-5) powder inhalation in the treatment of chronic obstructive pulmonary disease, can effectively relieve clinical symptoms, improve lung ventilation function, has important clinical value. The article published on the 07th issue of 2015, "Chinese Medical Engineering".

80 patients with chronic obstructive pulmonary disease admitted in our hospital from January 2012 to December 2014 were randomly divided into observation group and control group. The patients in the control group were treated with routine therapy. The observation group was treated with Tiantuo Bromide ammonium powder inhalation treatment, a course of treatment after comparing the two groups of patients with clinical results.

The clinical effective rate of the observation group was 92.5%, which was significantly higher than that of the control group (75.0%). The difference was statistically significant (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved